CHAPTER I Introduction
The sixth most common cancer in the world is head and neck squamous cell carcinoma (HNSCC) [1] . Anatomical sites in this category include the oral cavity, or9pharynx and larynx.
It has an estimated incidence of633,000 cases with 335,000 associated deaths atltlually [1, 2] .
This disease has typically been seen in heavy tobacco and alcohol users who are usually older males; however, HNSCC is appearing in younger patients without this history. Modern sexual practices, an increase in the number of sexual partners, and the human papilloma virus (HPV) are now risk factors in addition to alcohol and smoking. Oral-genital and oral-anal practices are the route of transmission to the oropharynx and oral cavity.
HPV associated and HPV non-associated squamous cell carcinomas (HPV-SCC and HNSCC) are histologic subtypes fmther classifying HNSCC. Potentially, these tumors can be sub-classified based on particular signaling pathways that are apparently aberrant. The identification of these subtypes, by recognition of these pathways, will potentially improve target-oriented therapeutics resulting in more positive patient outcomes [3] . This study, by evaluation of mTOR and EGFR pathways in particular, will explore the characteristics in HPV and non-HPV associated HNSCC and the therapeutic means by which to target these pathways.
Chapter II

Head and Neck Squamous Cell Carcinoma
A squamous cell is a flat, polygonal cell located in the most superior potiion of ce1iain types of epithelium. Its cytoplasm is almost entirely filled with keratin providing a physical protective barrier to external environments. The malignant proliferation of this cell is the disease known as squamous cell carcinoma and is the cancer-type most capable of local spread and distant or metastatic spread. The primary locations for this disease process includes skin, oral cavity, esophagus, urinary tract, prostate, lungs, vagina, and cervix. Of these sites, four make up the majority of the cases which include head and neck cancer, esophageal cancer, non-melanoma skin cancer, and non-small cell lung cancer [l] . HNSCC makes up 90% of all head and neck cancers which include, anatomically, cancers of the nasal and paranasal sinuses, nasopharynx, oral cavity, oropllarynx, and larynx [l, 2, 3] . HNSCC can be further categorized according to its state of differentiation in degrees from well-differentiated to poorly differentiated. Its ability to produce keratin, corresponding to its degree of differentiation, is referred to as "keratinizing" or "non-keratinizing" squamous cell carcinoma.
Incidence and Etiology
HNSCC is the sixth most common cancer, globally, with an estimated 633,000 new cases, yearly, resulting in 335,000 annual deaths [l, 2, 3] . Geographically, Nmth America, Southeast Asia, Central and Western Europe, and Australia have the highest rates of incidence [2] . These tumors have commonalities such as male predominance, occurrence at 5th to 6 1 h decade, tobacco-alcohol association, betel nut chewing, HPV infection and are similar histologically [3, 4] .
Alcohol ancl tobacco
The synergistic effect of alcohol and tobacco use is the most imp011ant risk factor for developing HNSCC, though the mechanism by which they interact is still unclear. Alcohol( or ethanol), is not a carcinogen per se; however, it acts as a co-carcinogen by generating oxygen free radicals during its metabolism [5] . This process damages epithelial membrane constituents, alters DNA tumor-suppressor pathways, and amplifies intercellular signaling cascades causing chronic inflammation [5] . The effect of smoking on disease incidence is influenced by: the type of tobacco used (i.e. black tobacco), the age of smoking onset (i.e. longer duration), the number of cigarettes smoked per day, and deep inhalation [3] . The thousands of chemicals in tobacco leaves, and in particular, their combustion products, confer mutagenic effects on the cells of the head and neck mucosa [5] . The risk of HNSCC from smokeless tobacco is low in men and essentially non-existent in women in the United States. Due to mode of use and tobacco type, it is of increased significance in areas oflndia and Southeast Asia [5] . The "chewing" of betel quid is the most common etiological factor in these pai1s of the world. Betel quid is a combination of betel leaf, areca nut, and slaked lime. Often, tobacco is added and the product is known as gutka. It is consumed by placing the mixture between the cheek and gum where it is sucked or chewed and the chemically-infused saliva is either expectorated or swallowed. The use of gutka or betel quid imparts a euphoric, stimulating, but relaxing sensation which plays a major role in the abuse and dependence of this combination of substances. Alkaloids from the areca nut stimulate fibroblasts to produce collagen leading to fibrosis. This process is termedora/ submucous fibrosis and can occur anywhere from the oral cavity to the superior portion of the esophagus. This fibrosis undergoes transformation to squamous cell carcinoma at a rate of7.6% over a 17 year period [5] .
Human papilloma virus (HPV)
Human papilloma virus is the most common sexually transmitted infection in the United
States. There are over two hundred types of HPV; most are not harmful to humans. About fmiy types can infect the genital, oropharyngeal, and nasopharyngeal areas and of these, only nine are associated with cancer. The two types considered highest risk are HPV 16 and 18 which have a well-established association with cervical cancers. However, HPV 16 accounts for the majority ofHPV-associated HNSCC [2, 3, 6, 7] . It has been recently shown that HPV infection is seen in a significant portion ofHNSCC cases occurring in the oropharynx. This carcinomas has a particular prevalence for tissues making up Waldeyer's ring specifically, the lingual, palatine, and pharyngeal (adenoid) tonsils. These cancers are now subdivided into HPV associated (HPV-SCC) and non-HPV associated squamous cell (SCC) carcinomas.
HPV-SCG is a distinct entity which varies from conventional HNSCC in its demographics, behavior associations, and prognosis. Compared to conventional type, HPV-SCC occurs at a younger age of onset (below 40), is associated with specific sexual behaviors, and demonstrates an improved survival rate [8] . In the last twenty-five years, there has been an increase in incidence of HPV-SCC with a relatively stable number of cases of conventional HNSCC. At this rate, the number ofHPV-SCC's among males will surpass the incidence of cervical cancers by the year 2020 [3] . Some studies have demonstrated a positive and synergistic correlation between HPV, alcohol, and tobacco while others have failed to find any association [3, 11, 12] . Tobacco, alcohol, and HPV are risk factors that function independently or in combinations with one another [5] .
When compared to HNSCC, HPV-SCC follows a different disease course and, as a result, treatment due to fts unique pathogenesis [2, 3, 10] . The protein products of two oncogenes, designated E6 and E7, located in the HPV genome, play a significant role in the carcinogenesis ofHPV-SCC. Under circumstances not completely understood, the E6 oncoprotein binds to p53, which promotes its degradation. The p53 molecule is a tumor suppressor protein that manages the cell cycle preventing catastrophic, uncontrolled, neoplastic mitosis. This protein is aptly Further along in its progression from dysplasia to invasive SCC, LOH at 17p13 and p53 point mutations occur in 50% of HNSCC [8] . Other anomalies, such as amplification of 11q13 and cyclin DI are also observed in 40% of dysplastic and 30-60% ofHNSCC which confers a poorer prognosis and increased risk of metastasis. The above progression of events allows an individual cell to go from GI to S phases in the cell cycle allowing for uncontrolled and potentially catastrophic proliferation [17] .
Pathways of Pathogenesis Epidermal Growth Factor Receptor
The epidermal growth factor receptor (EGFR) is a protein on the cell surface that plays a vital role in cellular growth, metabolism, and proliferation. Growth factor proteins, such as EGF (epide1mal growth factor), TGF-u (tissue growth factor-alpha), and HB-EGF (heparin-binding epidermal growth factor), activate the EGFR pathway to initiate a cascade of molecular reactions resulting in cell proliferation via DNA synthesis.
Compared to normal mucosa, over expression ofEGFR is seen in 90% of HNSCC tumor cells and is associated with more aggressive tumors and decreased rates of survival. Therefore, targeting and inhibiting this pathway has been shown to increase survival especially with a therapeutic antibody, cetuximab, which binds to EGFR and competes with its indigenous ligands to prevent activation. However, resistance to EGFR inhibition usually occurs by means not entirely understood, such as utilizing other pathways to avoid apoptosis and allow continued growth [18] . 
Clinical and Histologic Features
HNSCC usually develops from a leukoplakic or erythroplakic lesion most frequently in the areas of the lateral and ventral tongue and floor of the mouth. Leukoplakia is a clinical expression describing a white plaque or patch that cannot be identified as any other singular entity. It is the most common precursor to HNSCC and has a conversion rate of 1-2% per year [4] . Erythroplakia are red patches or plaques that, likewise, cannot be categorized as any other disease process. These lesions are red, or mixed (erythroleukoplakias), and have a greater risk (90%) oftransfonnation to dysplasia, carcinoma in situ, or sec [19] .
HPV-SCC is seen, clinically, in the region known as Waldeyer's ring. It is most often found in the tonsillar crypts of the palatine and lingual tonsils. This location is unfortunate because the patient is usually unaware of its presence [19] . Patients usually become aware of the lesion due to dysphagia (difficulty in swallowing) or pain. As a result, these lesions tend to be larger and are more likely to have metastasized, compared to I-INSCC, when diagnosed [19] .
Microscopically, leukoplakia, the precursor lesion to SCC, is usually altered cytologically and/or architecturally. Early on, the lesion is characterized by simple hyperplasia, a thickening of the epithelium due to increased numbers of cells in the basal and parabasal strata. There is no change in the cytomorphology of the cells. When these architectural changes are combined with cytologic change; the term dysplasia is used. The cytologic criteria of dysplasia include a loss of polarity, an increased nuclear-to-cytoplasm ratio, and an increase in abnormal mitotic activity 
Treatment and Prognosis
A more favorable prognosis exists for HPV-SCC where the five year survival rate approaches 60%. In HNSCC, the survival rates drop closer to 46% [7] . Other studies have demonstrated similar trends. HPV-SCC was reported to have a 28% reduction in risk of death and a 49% reduction in risk of recurrence when compared to HNSCC [7] . It is thought that the poorest prognoses for HNSCC's may be in part due to molecule-genetic changes such as mutation in p53 and over expression of EGFR [8] . It is also thought that the more favorable prognosisfor HPV-SCC is to its harboring less p53 mutations [8] . There is also speculation that the immune response to the HPV oncoproteins E6/E7 may contribute to superior survival rates for HPV-SCC even though this mechanism still remains unclear [2, 21] .
Even though HNSCC and HPV-SCC are genetically and epidemiologically distinct, most clinical trials have not differentiated them as such when it comes to treatment [2, 13] . Both subtypes are treated with combinations of surgery, chemotherapy, and/or radiation therapy. In order to design such an entity-specific protocol, molecular targeting strategies are required to focus treatment to this distinctive subtype. Identification of "driver" mutations is essential to understand the molecular mechanisms of HNSCC or both subtypes [ 4, 18] . Therefore, based on the patient's specific genomic state, the treatments resulting from this design could target their tumors specifically and directly at the same time possibly eliminating unnecessary treatments, target prevention, decrease morbidity, and reduce treatment costs.
Chapter Ill
Materials and Methods
(This section was takenfi'om the WRNM1'.1C protocol IRBNet # 388953 entitled "Expression of pl 6, p53, EGFR, and mTOR on HPV and non-HPV Associated Head and Neck
Squamous Cell Carcinoma. ")
Twenty Visualization was evaluated using the manufacturer's detection systems. The system used indirect detection of antigen, beginning with a rabbit antidinitrophenol primary antibody, then by a secondary biotinylated antibody and followed lastly by streptavidinconjugated alkaline phosphatase as the chromogenic enzyme.
All slides were scanned at 40x using an Aperio CS Scanscope (Aperio, Vista, CA) and quantified. Imnmnoexpression of p53 was quantified as positive or negative, while EGFR, p16, pAKT473, and pS6 were quantified according to percent of cells stained. In situ hybridization ofHPV 16/18 was characterized as positive or negative. Fields for each stain were added to the previously created de-identified database (Appendix A).
Chapter IV RESULTS
The results for this interim analysis, extrapolated from 57 n/a p n/a n/a n/a n/a n/• n/a n/a n/• 0 0 60% 16 M 38 n/a p n/a n/a n/a n/a n/a n/a n/a n/a 0 0 positivity to HPV testing [13] . The findings of this study may indicate a potential difference experienced in our military when compared to the general population, specifically, that it is at higher risk for HPV-SCC, possibly due to an increase in sexual partners and/or behaviors. 
